Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study

• Sigrun Thorsteinsdottir,
• Paul W. Dickman,
• Ola Landgren,
• Cecilie Blimark,
• Malin Hultcrantz,
• Ingemar Turesson,
• Magnus Björkholm,
• Sigurdur Y. Kristinsson

Affiliations

Sigrun Thorsteinsdottir

Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland;Faculty of Medicine, University of Iceland, Reykjavik, Iceland

Paul W. Dickman

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Ola Landgren

Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, NY, USA

Cecilie Blimark

Department of Internal Medicine, Hematology Section, Sahlgrenska University Hospital, Gothenburg, Sweden

Malin Hultcrantz

Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, NY, USA;Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

Ingemar Turesson

Department of Hematology and Coagulation Disorders, Skane University Hospital, Malmo, Sweden

Magnus Björkholm

Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

Sigurdur Y. Kristinsson

Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland;Faculty of Medicine, University of Iceland, Reykjavik, Iceland;Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden